Welcome : Guest

EDAP TMS S.A. (France) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about EDAP TMS S.A., which is principally involved in the Manufacture of Minimally-Invasive Medical Devices. Illustrated with 39 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-33935
Price: $1950
Company Type: Public
Pages: 42
Date: November 2016
Market Data Tables: 39

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Edap Tms S.A.’s Sales by Business Segment (2014-2015) in Percentage for HIFU Division (High Intensity Focused Ultrasound), and UDS Division (Urology Devices and Services)......3
Radiotherapy......5
Table 2: Radiotherapy Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Americas, Asia-Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Japan......5
Molecular Monitoring Oncology......6
Table 3: Molecular Monitoring Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......6
Breast Cancer Diagnoses......7
Table 4: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......7
Brachytherapy......8
Table 5: Brachytherapy Treatment (Body Sites) Market in the US (2015) - Percentage Share Breakdown by Value Sales for Breast, Liver, Prostate and Others......8
Surgical Robotics......9
Table 6: Surgical Robotics Market by Type in the US (2015) - Percentage Share Breakdown by Value for Intuitive Surgical (Prostatectomies and Hysterectomies), and Other (Mako Surgical, Mazor Robotics, Hansen and Other)......9
Clinical Oncology......10
Table 7: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......10
Diagnostic Test......11
Table 8: Diagnostic Test Sales by Category in the US (2015) - Percentage Market Share Breakdown by No. of Solid Tumour Patients for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......11
Table 9: Diagnostic Testing Sales by Category in the US (2015) - Percentage Share Breakdown by Value for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......12
Molecular Diagnostics and Genetic Testing......13
Table 10: Spending on Molecular Diagnostics and Genetic Testing by Payer in the US (2015) - Percentage Market Share Breakdown by Value for Cancer, Infectious Diseases, Inhired Conditions and Others......13
Cancer Care......14
Table 11: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others*......14
Table 12: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......15
Table 13: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......16
Cancer-Associated Mucositis......17
Table 14: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......17
New Patients with Cancer......18
Table 15: New Patients with Cancer by Site in the US (2015) - Percentage Market Share Breakdown by volume for Colorectal, Lung and Bronchus, Melanoma, Pancreas, and Others......18
Table 16: New Patients with Cancer in Stage 3/4 by Site in the US (2015) - Percentage Market Share Breakdown by Volume for Colorectal, Lung and Bronchus, Pancreas and Others......19
No. of Primary Liver Cancer......20
Table 17: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......20
No. of Solid Cancer Tumor Patients......21
Table 18: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......21
Number of Cancer Patients......22
Table 19: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......22
Table 20: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......23
Oncology......24
Table 21: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......24
Table 22: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......25
Table 23: Oncology Market by Product Segment Worldwide (2015) - Percentage Breakdown by Value for Dialysis Catheters, Enteral Feeding, Peripherally Inserted Central Catheters, Ports, Ultrasound, and Others......26
Table 24: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......27
Gram Infections......28
Table 25: Gram Infection Market by Segment in European Union (2015) - Percentage Share Breakdown by Volume for Abdominal / Pelvic, Gastrointestinal/Biliary, Genitourinary, Lower Respiratory, Skin, Systemic, and Other......28
Table 26: Gram Infection Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Abdominal / Pelvic, Gastrointestinal/Biliary, Genitourinary, Lower Respiratory, Skin, Systemic, and Others......29
Urinary Incontinence......30
Table 27: Prevalence of Urinary Incontinence by Gender in the US (2015) - Percentage Share Breakdown for Men and Women......30
Table 28: Prevalence of Urinary Incontinence in Women (Age Group (>60)) by Type in the US (2015) - Percentage Share Breakdown for Did Not Experience, and Experience......31
Table 29: Prevalence of Urinary Incontinence in Women (Age Group (18-44)) by Type in the US (2015) - Percentage Share Breakdown for Did Not Experience, and Experience......32
Urinary Continence......33
Table 30: Urinary Continence Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Americas, Europe, and Rest of World......33
Oncology......34
Table 31: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......34
Radiation Oncology Equipment......35
Table 32: Market Shares of Leading Radiation Oncology Equipment Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Elekta, Siemens AG, Varian Medical Systems and Others......35
Radiotherapy Equipment......36
Table 33: Market Shares of Leading Radiotherapy Equipment Providers in China (2015) - Percentage Breakdown by Value for Elekta, Neusoft Corporation, Shinva Medical Instrument Co., Ltd., Siemens AG, and Varian, Inc.......36
Table 34: Market Shares of Leading Radiotherapy Treatment Companies Worldwide (2015) - Percentage Share Breakdown by Volume for Accuray Incorporated, Elekta, Siemens Healthcare, and Varian Medical Systems......37
Table 35: Market Shares of Leading High-End Radiotherapy Equipment Manufacturers in China (2015) - Percentage Share Breakdown by Value for Elekta, SHINVA Medical Instrument Co., Ltd., Varian Medical Systems and Others......38
Table 36: Market Shares of Leading High-End Radiotherapy Equipment Manufacturers in China (2015) - Percentage Share Breakdown by Value for Elekta AB, SHINVA Medical Instrument Co., Ltd., Siemens Healthcare Global, Varian Medical Systems, and Others......39
Cancer Genetic Diagnostics......40
Table 37: Market Shares of Leading Cancer Genetic Diagnostics Reference Laboratory Services in the US (2015) - Percentage Breakdown by Value Sales for ARUP Laboratories, Clarient Diagnostic Services, Inc., Laboratory Corporation of America Holdings, Mayo Medical Laboratories, NeoGenomics, Inc., Quest Diagnostics Incorporated and AmeriPath, Inc., and Others......40
Urinary Incontinence Therapeutics......41
Table 38: Market Shares of Leading Urinary Incontinence Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Eli Lilly and Company, Johnson & Johnson, Novartis AG, Pfizer, Inc., and Others......41
Table 39: EDAP TMS S.A.’s Sales by Business Segment (2013-2014) in Percentage for HIFU Division (High Intensity Focused Ultrasound) and UDS Division (Urology Devices and Services)......42